Verastem (VSTM) Operating Expenses (2011 - 2026)

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Verastem was $247.32 million, up 55.8% year-over-year; for FY2025, it was $201.04 million, up 60.9% from FY2024.

• Annual Operating Expenses has increased for four consecutive years, with a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
• In prior years, Verastem's Operating Expenses was $124.96 million in FY2024 (+35.7%), $92.08 million in FY2023 (+21.9%), $75.53 million in FY2022 (+19.0%) and $63.46 million in FY2021 (-54.0%).
• The Q2 2026 figure stands as the highest quarterly Operating Expenses in data going back to Q1 2011.
• On a year-over-year basis, Operating Expenses has increased in each of the last 12 quarters, with growth averaging 53.1% over the last eight quarters.
• The strongest year-over-year quarter for Operating Expenses in the past five years was Q4 2025, with growth of 86.8%; the weakest was Q3 2021, with a decline of 76.7%.
• According to Business Quant data, Operating Expenses for the three prior quarters was $63.57 million (Q1 2026), $59.01 million (Q4 2025) and $51.96 million (Q3 2025).